Create stable, long-term investment portfolio with strong, consistent stocks.
Start Research-backed Investing ...Now.
BSE: 544091 | NSE: | Miscellaneous | Small Cap
Past 10 year’s financial track record analysis by Moneyworks4me indicates that Qualitek Labs Ltd is a below average quality company.
The key valuation ratios of Qualitek Labs Ltd's currently when compared to its past seem to suggest it is in the Fair zone.
The Price Trend analysis by MoneyWorks4Me indicates it is Weak which suggest that the price of Qualitek Labs Ltd is likely to Fall in the short term. However, please check the rating on Quality and Valuation before investing.
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.
| Mar'21 | Mar'22 | Mar'23 | TTM | |
|---|---|---|---|---|
| ROCE % ⓘ | 4.3% | 9.1% | 13.5% | - |
| Value Creation Index ⓘ | -0.7 | -0.4 | 0.0 | - |
Growth Parameters ⓘGrowth Parameters Colour Code Guide ⓘ | ||||
| Sales ⓘ | 6.4 | 12 | 19.1 | 19 |
| Sales YoY Gr. | - | 88.5% | 59.9% | - |
| Adj EPS ⓘ | 67.1 | 3.6 | 5.6 | 4 |
| YoY Gr. | - | -94.7% | 58.6% | - |
| BVPS (₹) ⓘ | -32.8 | 5.9 | 18.2 | 40 |
| Adj Net Profit ⓘ | 0.5 | 1.1 | 3.1 | 3 |
| Cash Flow from Ops. ⓘ | 1.4 | -5.1 | 7.2 | - |
| Debt/CF from Ops. ⓘ | 8.3 | -3.4 | 3.3 | - |
CAGR Colour Code Guide ⓘ
| 9 Years | 5 Years | 3 Years | 1 Years | |||||
|---|---|---|---|---|---|---|---|---|
| Sales ⓘ | NA | NA | NA | 59.9% | ||||
| Adj EPS ⓘ | NA | NA | NA | 58.6% | ||||
| BVPSⓘ | NA | NA | NA | 209.7% | ||||
| Share Price | - | - | - | - | ||||
Performance Ratio Colour Code Guide ⓘ
| Mar'21 | Mar'22 | Mar'23 | TTM | |
|---|---|---|---|---|
| Return on Equity % ⓘ | -204.5 | 137.3 | 51.8 | 13.8 |
| Op. Profit Mgn % ⓘ | 16.5 | 19.4 | 28.3 | NAN |
| Net Profit Mgn % ⓘ | 7.4 | 9.6 | 15.9 | 15.5 |
| Debt to Equity ⓘ | -48.9 | 9.1 | 2.4 | - |
| Working Cap Days ⓘ | 0 | 195 | 189 | 0 |
| Cash Conv. Cycle ⓘ | 0 | -36 | -5 | 0 |
Return on Equity has increased versus last 3 years average to 13.80%
Sales growth has been subdued in last 3 years 0.00%
Net Profit has been subdued in last 3 years 0.00%
Sales growth is not so good in last 4 quarters at 0.00%
| Standalone | Consolidated | |
|---|---|---|
| TTM EPS (₹) | 4 | 0.6 |
| TTM Sales (₹ Cr.) | 19.1 | 12 |
| BVPS (₹.) ⓘ | 40 | 0 |
| Reserves (₹ Cr.) ⓘ | 22 | 18 |
| P/BV ⓘ | 3.97 | 0.00 |
| PE ⓘ | 39.48 | 277.82 |
| From the Market | |
|---|---|
| 52 Week Low / High (₹) | 140.00 / 199.50 |
| All Time Low / High (₹) | 140.00 / 199.50 |
| Market Cap (₹ Cr.) | 117 |
| Equity (₹ Cr.) | 7.4 |
| Face Value (₹) | 10 |
| Industry PE ⓘ | 12 |
| Pledged * | 0.00 |
| PARTICULARS | Mar'21 | Mar'22 | Mar'23 |
|---|---|---|---|
| Sales | 6 | 12 | 19 |
| Operating Expenses ⓘ | 5 | 10 | 14 |
| Manufacturing Costs | 3 | 4 | 7 |
| Material Costs | 0 | 0 | 0 |
| Employee Cost | 1 | 3 | 4 |
| Other Costs ⓘ | 1 | 2 | 3 |
| Operating Profit ⓘ | 1 | 2 | 5 |
| Operating Profit Margin (%) | 16.3% | 19.3% | 27.7% |
| Other Income ⓘ | 0 | 0 | 0 |
| Interest ⓘ | 0 | 0 | 1 |
| Depreciation ⓘ | 0 | 0 | 1 |
| Exceptional Items ⓘ | 0 | 0 | 0 |
| Profit Before Tax ⓘ | 1 | 2 | 4 |
| Tax ⓘ | 0 | 0 | 1 |
| Profit After Tax | 0 | 1 | 3 |
| PAT Margin (%) | 7.3% | 9.5% | 15.5% |
| Adjusted EPS (₹) | 65.9 | 3.5 | 5.5 |
| Dividend Payout Ratio (%) | 0% | 0% | 0% |
| PARTICULARS | Mar'21 | Mar'22 | Mar'23 | |||||||
|---|---|---|---|---|---|---|---|---|---|---|
Equity and Liabilities | ||||||||||
| Shareholders Fund | 0 | 2 | 10 | |||||||
| Share Capital ⓘ | 0 | 0 | 5 | |||||||
| Reserves ⓘ | 0 | 1 | 4 | |||||||
| Minority Interest | 0 | 0 | 0 | |||||||
| Debt | 8 | 11 | 22 | |||||||
| Long Term Debt | 0 | 0 | 10 | |||||||
| Short Term Debt | 8 | 11 | 12 | |||||||
| Trade Payables | 2 | 2 | 4 | |||||||
| Others Liabilities ⓘ | 4 | 7 | 4 | |||||||
| Total Liabilities ⓘ | 15 | 22 | 40 | |||||||
Fixed Assets | ||||||||||
| Gross Block | 7 | 9 | 16 | |||||||
| Accumulated Depreciation | 1 | 1 | 2 | |||||||
| Net Fixed Assetsⓘ | 6 | 8 | 14 | |||||||
| CWIP ⓘ | 4 | 4 | 15 | |||||||
| Investmentsⓘ | 0 | 0 | 0 | |||||||
| Inventories | 0 | 0 | 0 | |||||||
| Trade Receivables | 1 | 2 | 6 | |||||||
| Cash Equivalents | 0 | 1 | 0 | |||||||
| Others Assetsⓘ | 2 | 7 | 5 | |||||||
| Total Assets ⓘ | 15 | 22 | 40 | |||||||
| PARTICULARS | Mar'21 | Mar'22 | Mar'23 |
|---|---|---|---|
| Cash Flow From Operating Activity ⓘ | 1 | -5 | 7 |
| PBT ⓘ | 1 | 2 | 4 |
| Adjustment ⓘ | 0 | 1 | 1 |
| Changes in Working Capital ⓘ | 1 | -7 | 2 |
| Tax Paid ⓘ | 0 | -1 | -1 |
| Cash Flow From Investing Activity ⓘ | -6 | -2 | -17 |
| Capex | -6 | -2 | -17 |
| Net Investments | 0 | 0 | 0 |
| Others ⓘ | 0 | 0 | 0 |
| Cash Flow From Financing Activityⓘ | 5 | 7 | 10 |
| Net Proceeds from Shares ⓘ | 0 | 0 | 0 |
| Net Proceeds from Borrowing ⓘ | -6 | 0 | 10 |
| Interest Paid ⓘ | 0 | 0 | -1 |
| Dividend Paid ⓘ | 0 | 0 | 0 |
| Others ⓘ | 11 | 7 | 1 |
| Net Cash Flow ⓘ | 0 | 0 | 0 |
| PARTICULARS | Mar'21 | Mar'22 | Mar'23 | |||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Ratios | ||||||||||
| ROE (%) | N/A | 136.3 | 50.49 | |||||||
| ROCE (%) | N/A | 12.35 | 17.79 | |||||||
| Asset Turnover Ratio | 0.44 | 0.65 | 0.62 | |||||||
| PAT to CFO Conversion(x) | N/A | -5 | 2.33 | Working Capital Days | ||||||
| Receivable Days | 69 | 52 | 76 | |||||||
| Inventory Days | 0 | 0 | 0 | |||||||
| Payable Days | 0 | 0 | 0 | |||||||
Qualitek Labs Limited was incorporated as Qualitek Labs Private Limited, a private limited company, at Delhi under the Companies Act, 2013 on May 17, 2018 and was granted the certificate of incorporation by the RoC. Subsequently, the company was converted into a public limited company under the Companies Act, 2013, pursuant to the approval accorded by its Shareholders at their extra-ordinary general meeting held on March 17, 2023. Consequently, the name of the company was changed to ‘Qualitek Labs Limited’ and a fresh certificate of incorporation consequent upon conversion from a private limited company to a public limited company was issued to the company by the RoC on April 26, 2023.
The company is primarily engaged in the business of provides testing, inspection, homologation, certification and consultancy services to various industries viz the automotive, defence, metals & metallurgy, environment and water, minerals, food & agriculture, pharma & healthcare. Within 5 years of incorporation, the company has commenced its business operation of providing services to its clients from a testing laboratory, which was set up in Pune in the year 2018. Later in the year 2022, the company expanded and established the second laboratory in Bhubaneshwar. Also, the company is in process of setting up another two testing laboratories at Pune and Noida.
The company’s team of professionals has the knowledge and experience to fully understand the challenges faced by the industry and try to comprehend the same. In addition, its experienced team has enabled it to build an effective business model that gives it control over its processes such as raw material procurement, marketing and sales through its network.
Business area of the company
The company is primarily engaged in the business of provides testing, inspection, homologation, certification and consultancy services to various industries viz the automotive, defense, minerals, environment & water, food & agriculture, pharma & healthcare, and metal & metallurgy.
Lab testing services of the company
Awards, accreditations and recognitions
History and milestones
MoneyWorks4Me rating and ranking of funds for SIP is available to subscribers only. Moneyworks4Me is not a rating and ranking agency, however it is required that users have a way of selecting funds and building a Portfolio. The method used by it are described below to enable users to understand the logic behind the rating and ranking Subscriber will find more details on this in the various content made available from time to time. In case you need more please write to besafe@moneyworks4Me.com
MoneyWorks4Me rates and ranks mutual funds based on the following data-driven system:
Funds ranking in screeners: Performance Consistency and Quality are two parameters used for ranking funds for SIP. The ranking as follows GG, GO, GR, OG, OO, OR, RG, RO and RR.
With the same color-coded funds, the one with the higher Average 3-year rolling returns (over 5 to 10 years), the number that appears in the Performance tag, ranks higher.
Here is the summary:
The third tag Upside Potential is not relevant for SIP. It is relevant for lumpsum investments in Mutual Funds.
Buy quality Stocks when they are available at reasonable prices and supported by an upward price trend and Sell when they are Overvalued using the Decizen Rating System. Covers 3500+ stocks
Download APP
